Phenotypic Detection and Occurrence of Extended-Spectrum Beta-Lactamases in Clinical Isolates of Klebsiella pneumoniae and Escherichia coli at a Tertiary Hospital in Trinidad & Tobago

被引:10
作者
Akpaka, Patrick E. [1 ]
Swanston, William H. [1 ]
机构
[1] Univ W Indies, Fac Med Sci, Dept Para Clin Sci, St Augustine, Trinidad Tobago
关键词
ESBL detection; E-test methods; E; coli; K; pneumoniae; antimicrobial susceptibility; Trinidad & Tobago; Tertiary hospital;
D O I
10.1590/S1413-86702008000600014
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The incidence and distribution of ESBL producing microorganisms such as E. coli and K. pneumoniae have been demonstrated and varies in different health care facilities and as well as other countries This study was carried out to determine the frequency of occurrence and the antimicrobial susceptibility pattern of ESBL producing E. coli and K. pneumoniae species from clinical isolates at a tertiary hospital in Trinidad & Tobago. Standard microbiological procedures and automated MicroScan System was used to identify, screen for putative ESBL production and determine antimicrobial susceptibility of 1,118 clinical isolates of Enterobacteriaceae species at the microbiology laboratory of the Eric Williams Medical Science Complex, Trinidad & Tobago over a 36 months period. All ESBL producing isolates flagged by the automated system were further confirmed by E-test method. The E-test confirmed a 15.2% ESBL rate among the K. pneumoniae isolates and 9.3% among the E. coli isolates. There was also a 1.8% rate of ESBL production in K. pneumoniae and 0.2% in E. coli isolates from specimens received from community health facilities into the laboratory. Isolates recovered from the intensive care unit of the hospital had 2.1% E. coli and 8.2% K. pneumoniae ESBL producers. Although all ESBL positive isolates were completely susceptible to imipenem and meropenem; and all positive K. pneumoniae isolates were susceptible to amikacin, there was a low susceptibility of ESBL positive E. coli to the aminoglycosides. However, susceptibility of these ESBL producing isolates to the fluoroquinolones varied. There is a high rate of ESBL production among isolates of E. coli and K. pneumoniae at this hospital that is linked to the extensive inappropriate use of third generation cephalosporins in the country. Further molecular studies are needed to characterize the types of these ESBL prevailing in the country.
引用
收藏
页码:516 / 520
页数:5
相关论文
共 28 条
  • [1] *AB BIOD E TEST, 2005, ESBL CEF CEF CLAV AC
  • [2] Extended-spectrum beta-lactamase-producing Salmonella Enteritidis in Trinidad and Tobago
    Cherian, BP
    Singh, N
    Charles, W
    Prabhakar, P
    [J]. EMERGING INFECTIOUS DISEASES, 1999, 5 (01) : 181 - 182
  • [3] Cherian BP, 2003, W INDIAN MED J, V52, P31
  • [4] *CLIN LAB STAND I, 2006, M100S16 CLSI
  • [5] Prevalence and molecular epidemiology of CTX-M extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Russian hospitals
    Edelstein, M
    Pimkin, M
    Palagin, I
    Edelstein, I
    Stratchounski, L
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (12) : 3724 - 3732
  • [6] Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: Project ICARE phase 2
    Fridkin, SK
    Steward, CD
    Edwards, JR
    Pryor, ER
    McGowan, JE
    Archibald, LK
    Gaynes, RP
    Tenover, FC
    [J]. CLINICAL INFECTIOUS DISEASES, 1999, 29 (02) : 245 - 252
  • [7] MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) results from Europe: comparison of antibiotic susceptibilities between countries and centre types
    Goossens, H
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 : 39 - 52
  • [8] An overview of pervasive computing
    Gupta, SKS
    Lee, WC
    Purakayastha, A
    Srimani, PK
    [J]. IEEE PERSONAL COMMUNICATIONS, 2001, 8 (04): : 8 - 9
  • [9] Nationwide study of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum β-lactamases in Spain
    Hernández, JR
    Martínez-Martínez, L
    Cantón, R
    Coque, TM
    Pascual, A
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (05) : 2122 - 2125
  • [10] Regional variation in the prevalence of extended-spectrum β-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998-2002)
    Hirakata, Y
    Matsuda, J
    Miyazaki, Y
    Kamihira, S
    Kawakami, S
    Miyazawa, Y
    Ono, Y
    Nakazaki, N
    Hirata, Y
    Inoue, M
    Turnidge, JD
    Bell, JM
    Jones, RN
    Kohno, S
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2005, 52 (04) : 323 - 329